Attaya Suvannasankha, Benga Kazeem, Paul MacLeod, Ewa Dlotko, Natalie Boytsov, Yevgeniy Samyshkin, Simon McNamara, Molly Purser, Sandhya Sapra, Martin Kaiser. "Life-years and quality-adjusted life-years with belantamab mafodotin, bortezomib, and dexamethasone vs alternative regimens in patients with Relapsed/Refractory multiple myeloma who received ≥1 prior line of therapy." Blood, 2025. doi:10.1182/blood-2025-4041